Abstract
Anxiety treatment protocols in adolescents generally follow the same guidelines as treatment of anxiety in adults. In order to provide a working framework that considers the presence of substance use disorders in relation to anxiety, a biological perspective on anxiety is presented with a focus on a common mechanisms in common with substance use disorders. The premise of a shared pathophysiology allows for a heuristic useful to treatment approaches for both conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abdallah, C. G., Coplan, J. D., Jackowski, A., Sato, J. R., Mao, X., Shungu, D. C., & Mathew, S. J. (2013). A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 23(4), 276–284.
Amaral, O. B., & Roesler, R. (2008). Targeting the NMDA receptor for fear-related disorders. Recent Patents on CNS Drug Discovery, 3, 166–178.
Bovasso, G. (2001). The long-term treatment outcomes of depression and anxiety comorbid with substance abuse. Journal of Behavioral Health Service & Research, 28, 42–57.
Brady, K. T., Sonne, S. C., & Roberts, J. M. (1995). Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. Journal of Clinical Psychiatry, 56, 502–505.
Bromet, E., Sonnega, A., & Kessler, R. C. (1998). Risk factors for DSM-III-R posttraumatic stress disorder: Findings from the National Comorbidity Survey. American Journal of Epidemiology, 147, 353–361.
Castle, D. J. (2008). Anxiety and substance use: Layers of complexity. Expert Review of Neurotherapeutics, 8, 493–501.
Clemens, K. J., & Vendruscolo, L. F. (2008). Anxious to drink: Gabapentin normalizes GABAergic transmission in the central amygdala and reduces symptoms of ethanol dependence. Journal of Neuroscience, 28, 9087–9089.
Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576.
Copeland, W. E., Keeler, G., Angold, A., & Costello, E. J. (2007). Traumatic events and posttraumatic stress in childhood. Archives of General Psychiatry, 64, 577–584.
Cottler, L. B., Compton, W. M., III, Mager, D., Spitznagel, E. L., & Janca, A. (1992). Posttraumatic stress disorder among substance users from the general population. American Journal of Psychiatry, 149, 664–670.
Delgado, M. R., Olsson, A., & Phelps, E. A. (2006). Extending animal models of fear conditioning to humans. Biological Psychology, 73, 39–48.
Dunner, D. L. (2001). Management of anxiety disorders: The added challenge of comorbidity. Depression and Anxiety, 13, 57–71.
Elzinga, B. M., Spinhoven, P., Berretty, E., de Jong, P., & Roelofs, K. (2009). The role of childhood abuse in HPA-axis reactivity in Social Anxiety Disorder: A pilot study. Biological Psychology, 83, 1–6.
Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164, 1476–1488.
Feldstein, E. S. W., Filbey, F. M., Chandler, L. D., & Hutchison, K. E. (2009). Exploring the relationship between depressive and anxiety symptoms and neuronal response to alcohol cues. In Alcoholism: Clinical and experimental research [epub ahead of print].
Finkelhor, D., Ormrod, R. K., & Turner, H. A. (2009). Lifetime assessment of poly-victimization in a national sample of children and youth. Child Abuse and Neglect, 33, 403–411.
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020). Pharmacotherapy of anxiety disorders: Current and emerging treatment options. Frontiers in Psychiatry, 11, 595584.
Goeders, N. E. (2003). The impact of stress on addiction. European Neuropsychopharmacology, 13, 435–441.
Griebel, G., & Holmes, A. (2013). 50 years of hurdles and hope in anxiolytic drug discovery. 12(9), 667–687.
Herry, C., & Garcia, R. (2002). Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice. Journal of Neuroscience, 22, 577–583.
Kabbaj, M., Norton, C. S., Kollack-Walker, S., Watson, S. J., Robinson, T. E., & Akil, H. (2001). Social defeat alters the acquisition of cocaine self-administration in rats: Role of individual differences in cocaine-taking behavior. Psychopharmacology (Berlin), 158, 382–387.
Kalivas, P. W. (2009). The glutamate homeostasis hypothesis of addiction. Nature Review Neuroscience, 10, 561–572.
Kendler, K. S., Davis, C. G., & Kessler, R. C. (1997). The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: A family history study. British Journal of Psychiatry, 170, 541–548.
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627.
Kim-Cohen, J., Caspi, A., Moffitt, T. E., Harrington, H., Milne, B. J., & Poulton, R. (2003). Prior juvenile diagnoses in adults with mental disorder: Developmental follow-back of a prospective-longitudinal cohort. Archives of General Psychiatry, 60, 709–717.
Kosten, T. A., Miserendino, M. J., & Kehoe, P. (2000). Enhanced acquisition of cocaine self-administration in adult rats with neonatal isolation stress experience. Brain Research, 875, 44–50.
Kranzler, H. R., Burleson, J. A., Del Boca, F. K., Babor, T. F., Korner, P., Brown, J., & Bohn, M. J. (1994). Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Archives of General Psychiatry, 51, 720–731.
Kushner, M. G., Sher, K. J., & Beitman, B. D. (1990). The relation between alcohol problems and the anxiety disorders. American Journal of Psychiatry, 147, 685–695.
Kushner, M. G., Abrams, K., Thuras, P., Hanson, K. L., Brekke, M., & Sletten, S. (2005). Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcoholism: Clinical and Experimental Research, 29, 1432–1443.
Ledgerwood, L., Richardson, R., & Cranney, J. (2004). D-cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement. Behavioral Neuroscience, 118, 505–513.
Ledgerwood, L., Richardson, R., & Cranney, J. (2005). D-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction. Biological Psychiatry, 57, 841–847.
Lejoyeux, M. (1996). Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism. Alcohol and Alcoholism, 31(1), 69–75.
Madayag, A., Lobner, D., Kau, K. S., Mantsch, J. R., Abdulhameed, O., Hearing, M., Grier, M. D., & Baker, D. A. (2007). Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. Journal of Neuroscience, 27, 13968–13976.
McRae, A. L., Sonne, S. C., Brady, K. T., Durkalski, V., & Palesch, Y. (2004). A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. American Journal of Addictions, 13, 53–63.
Milad, M. R., & Quirk, G. J. (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature, 420, 70–74.
Myers, K. M., & Davis, M. (2002). Behavioral and neural analysis of extinction. Neuron, 36, 567–584.
Myrick, H., Henderson, S., Brady, K. T., & Malcolm, R. (2001). Gabapentin in the treatment of cocaine dependence: A case series. Journal of Clinical Psychiatry, 62, 19–23.
Ori, R., Amos, T., Bergman, H., Soares-Weiser, K., Ipser, J. C., & Stein, D. J. (2015). Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. The Cochrane Database of Systematic Reviews, 5, CD007803.
Peters, J., LaLumiere, R. T., & Kalivas, P. W. (2008). Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats. Journal of Neuroscience, 28, 6046–6053.
Peters, J., Kalivas, P. W., & Quirk, G. J. (2009). Extinction circuits for fear and addiction overlap in prefrontal cortex. Learning and Memory, 16, 279–288.
Piazza, P. V., Deminiere, J. M., le Moal, M., & Simon, H. (1990). Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Research, 514, 22–26.
Quartermain, D., Mower, J., Rafferty, M. F., Herting, R. L., & Lanthorn, T. H. (1994). Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. European Journal of Pharmacology, 257, 7–12.
Quirk, G. J., Repa, C., & LeDoux, J. E. (1995). Fear conditioning enhances short-latency auditory responses of lateral amygdala neurons: Parallel recordings in the freely behaving rat. Neuron, 15, 1029–1039.
Randall, C. L., Johnson, M. R., Thevos, A. K., Sonne, S. C., Thomas, S. E., Willard, S. L., Brady, K. T., & Davidson, J. R. (2001). Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depression and Anxiety, 14, 255–262.
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association, 264, 2511–2518.
Roberto, M., Madamba, S. G., Moore, S. D., Tallent, M. K., & Siggins, G. R. (2003). Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proceedings of the National Academy of Sciences of the United States of America, 100, 2053–2058.
Roberto, M., Gilpin, N. W., O’Dell, L. E., Cruz, M. T., Morse, A. C., Siggins, G. R., & Koob, G. F. (2008). Cellular and behavioral interactions of gabapentin with alcohol dependence. Journal of Neuroscience, 28, 5762–5771.
Roberto, M., Cruz, M. T., Gilpin, N. W., Sabino, V., Schweitzer, P., Bajo, M., Cottone, P., Madamba, G., Stouffer, D. G., Zorrilla, E. P., Koob, G. F., Siggings, G. R., & Parsons, L. H. (2020). Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biological Psychiatry, 67(9), 831–839.
Saraceno, L., Munafo, M., Heron, J., Craddock, N., & van den Bree, M. B. (2009). Genetic and non-genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence: A review. Addiction, 104, 1100–1121.
Sesack, S. R., Deutch, A. Y., Roth, R. H., & Bunney, B. S. (1989). Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. Journal of Comparative Neurology, 290, 213–242.
Shaham, Y., & Stewart, J. (1994). Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology (Berlin), 114, 523–527.
Sierra-Mercado, D., Jr., Corcoran, K. A., Lebron-Milad, K., & Quirk, G. J. (2006). Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction. European Journal of Neuroscience, 24, 1751–1758.
Silverstone, P. H., Williams, R., McMahon, L., Fleming, R., & Fogarty, S. (2008). Alcohol significantly lowers the seizure threshold in mice when co-administered with bupropion hydrochloride. Annals of General Psychiatry, 7, 11.
Suliman, S., Mkabile, S. G., Fincham, D. S., Ahmed, R., Stein, D. J., & Seedat, S. (2009). Cumulative effect of multiple trauma on symptoms of posttraumatic stress disorder, anxiety, and depression in adolescents. Comprehensive Psychiatry, 50, 121–127.
Walker, D. L., Ressler, K. J., Lu, K. T., & Davis, M. (2002). Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience, 22, 2343–2351.
Wensel, T. M., Powe, K. W., & Cates, M. E. (2012). Pregabalin for the treatment of generalized anxiety disorder. The Annals of Pharmacotherapy, 46(3), 424–429.
Will, M. J., Watkins, L. R., & Maier, S. F. (1998). Uncontrollable stress potentiates morphine’s rewarding properties. Pharmacology, Biochemistry, and Behavior, 60, 655–664.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Grados, M.A., Rizwan, B. (2023). A Common Mechanism for Anxiety Disorders and Drug Addiction: Implications for Current and Novel Pharmacological Treatments. In: McKay, D., Storch, E.A. (eds) Handbook of Child and Adolescent Anxiety Disorders. Springer, Cham. https://doi.org/10.1007/978-3-031-14080-8_24
Download citation
DOI: https://doi.org/10.1007/978-3-031-14080-8_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14079-2
Online ISBN: 978-3-031-14080-8
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)